vimarsana.com

Latest Breaking News On - Taigen biotechnology - Page 1 : vimarsana.com

TaiGen Enters Exclusive License Agreement with YSP - Thailand Business News

TaiGen Enters Exclusive License Agreement with YSP

GPCR Therapeutics Demonstrates Clinical Improvement in Mobilization of Hematopoietic Stem Cells Using GPC-100/Burixafor in Clinical Pharmacology in Drug Development

GPCR Therapeutics, Inc., a clinical stage, international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, announced today publication of their paper in Clinical Pharmacology in Drug Development (1), in collaboration with Taiwan’s .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.